PE20030508A1 - Un proceso nuevo para obtener formulaciones acuosas de principios activos sensibles a la oxidacion y las soluciones asi obtenidas - Google Patents
Un proceso nuevo para obtener formulaciones acuosas de principios activos sensibles a la oxidacion y las soluciones asi obtenidasInfo
- Publication number
- PE20030508A1 PE20030508A1 PE2001000715A PE2001000715A PE20030508A1 PE 20030508 A1 PE20030508 A1 PE 20030508A1 PE 2001000715 A PE2001000715 A PE 2001000715A PE 2001000715 A PE2001000715 A PE 2001000715A PE 20030508 A1 PE20030508 A1 PE 20030508A1
- Authority
- PE
- Peru
- Prior art keywords
- deoxygenation
- oxidation
- solution
- concentration
- solutions
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D19/00—Degasification of liquids
- B01D19/0005—Degasification of liquids with one or more auxiliary substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Removal Of Specific Substances (AREA)
Abstract
SE REFIERE A UN PROCESO PARA LA PREPARACION DE UNA SOLUCION ACUOSA DE UN PRINCIPIO ACTIVO DE NATURALEZA FENOLICA COMO PARACETAMOL, SENSIBLE A LA OXIDACION, CONSERVANDOLA POR UN PERIODO PROLONGADO, CARACTERIZADO POR LA DESOXIGENACION DE LA SOLUCION SE DA MEDIANTE EL BURBUJEO DE AL MENOS UN GAS INERTE (NITROGENO) Y PONIENDOLA BAJO VACIO, JUSTO HASTA CONTENER UNA CONCENTRACION DE OXIGENO DE MENOS DE 2ppm EN QUE LA SOLUCION ACUOSA PRECIPITADA DEL PRINCIPIO ESTA CUBIERTA DE UNA ATMOSFERA DE GAS INERTE (ARGON) SE LA PONE EN UN ENVASE ENCERRADO EN QUE LA PRESION ACTUAL ES UN MAXIMO DE 65000 Pa; DE MODO QUE LA CONCENTRACION DE OXIGENO ES MENOS DE O IGUAL A 2ppm, SE EMPLEA EL EFECTO DE DESOXIGENACION ANADIENDO UN AGENTE ANTIOXIDANTE (TIOLES, ACIDO ASCORBICO, AZUCARES REDUCTORES) A LA SOLUCION; SE COMPLETA EL EFECTO DE LA DESOXIGENACION POR ADICION DE ACIDO HIDROXIPOLICARBOXILICO COMO ACIDO CITRICO, ACIDO TARTARICO, GLUCONICO, SACARICO, CITRAMALICO, MALICO, EN UNA CONCENTRACION DE 5mg/100ml A 20mg/100ml
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0007231A FR2809619B1 (fr) | 2000-06-06 | 2000-06-06 | Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20030508A1 true PE20030508A1 (es) | 2003-06-25 |
Family
ID=8851012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2001000715A PE20030508A1 (es) | 2000-06-06 | 2001-07-16 | Un proceso nuevo para obtener formulaciones acuosas de principios activos sensibles a la oxidacion y las soluciones asi obtenidas |
Country Status (16)
Country | Link |
---|---|
US (1) | US6992218B2 (es) |
CN (1) | CN1556694A (es) |
AP (1) | AP1880A (es) |
AU (1) | AU2001266120A1 (es) |
CA (1) | CA2415403C (es) |
CZ (1) | CZ200313A3 (es) |
DZ (1) | DZ3384A1 (es) |
FR (1) | FR2809619B1 (es) |
MA (1) | MA26926A1 (es) |
MX (1) | MXPA03000001A (es) |
NZ (1) | NZ523458A (es) |
PE (1) | PE20030508A1 (es) |
RU (1) | RU2003100090A (es) |
TW (1) | TWI237570B (es) |
WO (1) | WO2001093830A1 (es) |
YU (1) | YU103A (es) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2809619B1 (fr) * | 2000-06-06 | 2004-09-24 | Pharmatop | Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention |
ITMI20012135A1 (it) | 2001-10-16 | 2003-04-16 | Bioren S A | Soluzioni iniettabili pronte all'uso di paracetamolo |
FR2832063B1 (fr) * | 2001-11-15 | 2004-08-27 | Aguettant Lab | Procede de production de solutions stables de substances phenoliques et les solutions en resultant |
FR2851164B1 (fr) | 2003-02-14 | 2005-04-22 | Xuan Tho Nguyen | Formulation liquide injectable de paracetamol |
US20050020554A1 (en) * | 2003-06-06 | 2005-01-27 | Ahmed Salah U. | Stability of hormone formulations |
FR2880807B1 (fr) * | 2005-01-19 | 2007-04-13 | Aguettant Sa Lab | Composition pharmaceutique injectable |
AU2006213673A1 (en) | 2005-02-09 | 2006-08-17 | Santen Pharmaceutical Co., Ltd. | Formulations for ocular treatment |
DE102005037653A1 (de) * | 2005-08-05 | 2007-02-15 | Theraselect Gmbh | Stabile, flüssige Formulierung von Paracetamol |
US20070077303A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for providing oxidatively stable ophthalmic compositions |
FR2894154B1 (fr) * | 2005-12-06 | 2008-03-14 | Pharmatop Scr | Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation. |
CA2635797C (en) | 2006-02-09 | 2015-03-31 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
JP5506378B2 (ja) | 2006-03-23 | 2014-05-28 | 参天製薬株式会社 | 血管透過性に関連する疾患または病気のための製剤および方法 |
US20070249727A1 (en) | 2006-04-21 | 2007-10-25 | The Proctor & Gamble Company | Compositions and kits useful for treatment of respiratory illness |
US10022339B2 (en) | 2006-04-21 | 2018-07-17 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
AU2006346318B2 (en) | 2006-07-18 | 2011-02-10 | Genfarma Laboratorio S.L. | Injectable liquid paracetamol formulation |
EP1992334A1 (en) * | 2007-05-08 | 2008-11-19 | Docpharma NV/SA | Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation |
DE102007026975A1 (de) * | 2007-06-01 | 2008-12-04 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Antioxidationsmittel für Lebensmittel |
WO2009081283A2 (en) * | 2007-06-18 | 2009-07-02 | Combino Pharm, S.L. | Aqueous formulations of acetaminophen for injection |
EP2170313A2 (en) * | 2007-06-18 | 2010-04-07 | Combino Pharm, S.L. | Aqueous formulations of acetaminophen for injection |
US9399012B2 (en) | 2007-11-13 | 2016-07-26 | Mallinckrodt Ip | Reduced dose intravenous acetaminophen |
WO2009098716A2 (en) * | 2008-01-17 | 2009-08-13 | Aptuit Laurus Private Limited | Stable pharmaceutical aqueous compositions |
FR2926992B1 (fr) * | 2008-02-06 | 2011-01-14 | Moly Pharma | Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution |
US20110097470A1 (en) * | 2008-06-11 | 2011-04-28 | Joerg Kowalczyk | Highly active antioxidant based on trehalulose |
EP2243477A1 (de) | 2009-04-22 | 2010-10-27 | Fresenius Kabi Deutschland GmbH | Paracetamol zur parenteralen Verabreichung |
US8404748B2 (en) * | 2009-08-13 | 2013-03-26 | Neogen N.V. | Storage-stable formulation of paracetamol in aqueous solution |
EP2464332B1 (en) | 2009-08-13 | 2016-03-02 | Neogen N.V. | Storage-stable formulation of paracetamol in aqueous solution |
CN102548639B (zh) * | 2009-09-24 | 2015-04-29 | 株式会社东芝 | 二氧化碳吸收液 |
US20120245230A1 (en) | 2009-12-10 | 2012-09-27 | Tecnimede-Sociedade Tecnico- Medicinal, S.A. | Method and composition for preparing stable liquid formulations of paracetamol |
US20110207824A1 (en) * | 2010-02-25 | 2011-08-25 | Moly Pharma | Formulation of an injectable paracetamol solution, method for preparing and packaging such a solution and device for packaging such a solution |
CN103476395A (zh) * | 2011-02-10 | 2013-12-25 | 尼奥根公司 | 在水溶液中贮存稳定的扑热息痛制剂 |
LT3287123T (lt) | 2011-03-04 | 2020-06-10 | Grünenthal GmbH | Vandeninė farmacinė tapentadolio kompozicija, skirta gerti |
ES2414557B1 (es) * | 2012-01-16 | 2014-06-10 | Novocat Farma, S.A. | Composición acuosa de paracetamol para inyección |
ITMI20121154A1 (it) | 2012-06-29 | 2013-12-30 | Sint Sa | Soluzione iniettabile di acetaminofene per la somministrazione spinale |
CN103006550A (zh) * | 2012-12-11 | 2013-04-03 | 哈药集团三精制药股份有限公司 | 一种胞磷胆碱钠注射液及其制备方法 |
US20140303254A1 (en) * | 2013-04-08 | 2014-10-09 | InnoPharma Licensing LLC | Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation |
UY35988A (es) | 2014-02-27 | 2015-09-30 | Sint Sa | Proceso para la producción de una solución inyectable de noradrenalina de baja concentración |
BR102014005885B1 (pt) | 2014-03-13 | 2021-04-13 | Biotec Biológica Indústria Farmacêutica Ltda E.P.P | Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso |
WO2016008546A1 (en) * | 2014-07-18 | 2016-01-21 | Everbright Pharmaceuticals S.A.R.L. | Aqueous formulation comprising paracetamol and ibuprofen |
CN104288099B (zh) * | 2014-09-25 | 2017-02-15 | 西安仁仁药业有限公司 | 一种布洛芬注射液的制备方法 |
MX2017012312A (es) * | 2015-03-27 | 2018-01-18 | Gruenenthal Gmbh | Formulacion estable para administracion parenteral de tapentadol. |
RS62844B1 (sr) | 2015-06-18 | 2022-02-28 | Estetra Srl | Orodisperzibilna dozna jedinica koja sadrži komponentu estetrola |
CA2988498C (en) | 2015-06-18 | 2022-02-08 | Mithra Pharmaceuticals S.A. | Orodispersible dosage unit containing an estetrol component |
EP3120837A1 (de) | 2015-07-22 | 2017-01-25 | Stada Arzneimittel Ag | Verfahren zur herstellung einer bortezomibester-lösung |
PT3411004T (pt) | 2016-02-05 | 2021-05-11 | Innopharma Inc | Processo de fabrico de um saco de perfusão estável e pronto para utilização para uma formulação sensível à oxidação |
MX2019003257A (es) | 2016-09-23 | 2019-06-10 | Gruenenthal Gmbh | Formulacion estable para la administracion parenteral de tapentadol. |
WO2018140894A1 (en) | 2017-01-30 | 2018-08-02 | Nevakar, Inc | Norepinephrine compositions and methods therefor |
WO2018192664A1 (en) * | 2017-04-20 | 2018-10-25 | Hyloris Developments Sa | METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF |
WO2019150381A1 (en) * | 2018-02-01 | 2019-08-08 | Joshi Mahendra R | A stable pharmaceutical composition and process for production of isoproterenol hydrochloride injection |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
CA3100314A1 (en) | 2018-05-16 | 2019-11-21 | Bayer Healthcare Llc | High concentration suspension formulation for cold and flu soft gel capsule medications |
EP3863589A1 (en) * | 2018-10-08 | 2021-08-18 | Merz Pharma GmbH & Co. KGaA | Neurotoxin prefilled vial |
US10478453B1 (en) | 2019-01-15 | 2019-11-19 | Exela Pharma Sciences, LLC | Stable, highly pure L-cysteine compositions for injection and methods of use |
CN113105040A (zh) * | 2021-04-02 | 2021-07-13 | 武汉工控工业技术研究院有限公司 | 一种自然水体无菌处理及长期保存技术 |
CN116803376B (zh) * | 2023-08-04 | 2024-02-13 | 广州白云山星群(药业)股份有限公司 | 一种复方愈创木酚磺酸钾口服溶液的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3443004A (en) * | 1965-04-08 | 1969-05-06 | Ciba Geigy Corp | Injectable solution containing 6-chloroor 6-trifluoromethyl-7-sulfamyl - 1,2,4-benzothiodiazine-1,1-dioxide diuretic |
DD153578A1 (de) * | 1980-10-22 | 1982-01-20 | Hans Meffert | Stabilisierung von oxydationsempfindlichen wirkstoffen,vorrangig dithranol in arzneizubereitungen |
RO93391B (ro) * | 1984-12-20 | 1988-03-31 | Eli Lilly And Company | Procedeu pentru prepararea unor saruri de dobutamina |
JPH07502544A (ja) * | 1992-10-21 | 1995-03-16 | アルコン ラボラトリーズ,インコーポレイテッド | 眼内組織潅注用および眼内外科処置中の瞳孔散大維持用組成物 |
WO1994013274A1 (en) * | 1992-12-10 | 1994-06-23 | Abbott Laboratories | Stabilized catecholamine solutions |
FR2740338B1 (fr) * | 1995-12-01 | 1997-12-05 | Rhone Poulenc Rorer Sa | Compositions pharmaceutiques stabilisees contenant de la dobutamine |
FR2751875B1 (fr) * | 1996-08-05 | 1998-12-24 | Scr Newpharm | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation |
FR2809619B1 (fr) * | 2000-06-06 | 2004-09-24 | Pharmatop | Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention |
-
2000
- 2000-06-06 FR FR0007231A patent/FR2809619B1/fr not_active Expired - Lifetime
-
2001
- 2001-06-06 RU RU2003100090/15A patent/RU2003100090A/ru not_active Application Discontinuation
- 2001-06-06 YU YU103A patent/YU103A/sh unknown
- 2001-06-06 AP APAP/P/2002/002711A patent/AP1880A/en active
- 2001-06-06 AU AU2001266120A patent/AU2001266120A1/en not_active Abandoned
- 2001-06-06 CN CNA018136702A patent/CN1556694A/zh active Pending
- 2001-06-06 CA CA2415403A patent/CA2415403C/fr not_active Expired - Lifetime
- 2001-06-06 DZ DZ013384A patent/DZ3384A1/xx active
- 2001-06-06 CZ CZ200313A patent/CZ200313A3/cs unknown
- 2001-06-06 US US10/332,060 patent/US6992218B2/en not_active Expired - Lifetime
- 2001-06-06 MX MXPA03000001A patent/MXPA03000001A/es active IP Right Grant
- 2001-06-06 NZ NZ523458A patent/NZ523458A/en not_active IP Right Cessation
- 2001-06-06 WO PCT/FR2001/001749 patent/WO2001093830A1/fr active IP Right Grant
- 2001-07-16 PE PE2001000715A patent/PE20030508A1/es not_active Application Discontinuation
- 2001-07-31 TW TW090118576A patent/TWI237570B/zh not_active IP Right Cessation
-
2003
- 2003-01-03 MA MA26990A patent/MA26926A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CA2415403A1 (fr) | 2001-12-13 |
TWI237570B (en) | 2005-08-11 |
CZ200313A3 (cs) | 2003-11-12 |
CN1556694A (zh) | 2004-12-22 |
YU103A (sh) | 2006-05-25 |
AU2001266120A1 (en) | 2001-12-17 |
FR2809619A1 (fr) | 2001-12-07 |
MA26926A1 (fr) | 2004-12-20 |
AP2002002711A0 (en) | 2002-12-31 |
RU2003100090A (ru) | 2004-05-10 |
WO2001093830A1 (fr) | 2001-12-13 |
CA2415403C (fr) | 2011-05-24 |
DZ3384A1 (fr) | 2001-12-13 |
MXPA03000001A (es) | 2004-03-19 |
US6992218B2 (en) | 2006-01-31 |
AP1880A (en) | 2008-08-19 |
NZ523458A (en) | 2005-08-26 |
US20040054012A1 (en) | 2004-03-18 |
FR2809619B1 (fr) | 2004-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20030508A1 (es) | Un proceso nuevo para obtener formulaciones acuosas de principios activos sensibles a la oxidacion y las soluciones asi obtenidas | |
UY27342A1 (es) | Agente anticolinérgico cristalino, procedimiento para su preparación y su utilización para la preparación de un medicamento | |
AR020417A1 (es) | Fertilizante folial y metodo de empleo. | |
EA200700074A1 (ru) | Способ повышения скорости заживления повреждения ( варианты ), устройство доставки перекиси водорода и композиция для лечения повреждений у млекопитающих | |
IL145333A0 (en) | Dopant pastes for the production of p,p+and n, n+regions in semiconductors | |
MX2007006539A (es) | Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel. | |
WO2006023616A3 (en) | Conversion of nitrogen dioxide (no2) to nitric oxide (no) | |
JP2012517420A5 (es) | ||
DE69631587D1 (de) | Sauerstoff produzierende bandage | |
PA8525201A1 (es) | Tetrazolil-fenil acetamidas como activadores de la glucoquinasa | |
DE50208783D1 (de) | Selbstschäumende oder schaumförmige zubereitungen mit anorganischen gelbildnern und organischen hydrokolloiden | |
AR095758A1 (es) | Un catalizador para la deshidrogenación oxidativa de alcanos y/o la oxidación de alquenos | |
WO1991008981A3 (en) | Solutions for stabilizing hydrogen peroxide containing solutions | |
CN104117057A (zh) | 一种负载酶的具有释氧功能的水凝胶组合物及其形成的水凝胶 | |
WO2021243183A8 (en) | Formulations and methods for treating acute respiratory distress syndrome, asthma, or allergic rhinitis | |
CN112246066A (zh) | 一种臭氧-紫外联用催化氧化消毒方法 | |
CN103181911B (zh) | 一种阴道泡腾片 | |
MX2012001816A (es) | Formulaciones y metodos que emplean desinfectante anhidro. | |
ES2061104T3 (es) | Procedimiento para la preparacion de soluciones de alquiltetrahidro-antrahidroquinonas y su empleo como solucion de trabajo en la preparacion de peroxido de hidrogeno segun el procedimiento de la antraquinona. | |
AR031115A1 (es) | Un proceso para la preparacion de una solucion acuosa de un principio activo de naturaleza fenolica, sensible a la oxidacion, utilizacion de dicha solucion y soluciones inyectables | |
MX2023003356A (es) | Barrera de tratamiento de heridas sin contacto y metodo de tratamiento de heridas sin contacto. | |
CA2903759C (en) | Concentrated aqueous azalide formulations | |
CN102972449A (zh) | 新型杀菌剂 | |
Tyagi | GaAs (100) Surface Passivation with Sulfide and Fluoride Ions | |
WO2022178254A3 (en) | Dithioacetal-based covalent organic frameworks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |